James Kinley

James Kinley

Director of Finance/CFO at GREY MATTERS HEALTH INC.

Net worth: 105 307 $ as of 30/05/2026

48 year
Health Technology
Commercial Services
Communications

Profile

James F.
Kinley
is currently Independent Director at Medicure, Inc. since 2022, Independent Director at Waverley Pharma, Inc. since 2024, Chief Financial Officer at Cytophage Technologies Ltd. starting 2026, Chief Financial Officer & Secretary at Grey Matters Health, Inc. since 2022, and Chief Financial Officer at Algernon Neuroscience, Inc. Formerly, Mr. Kinley was Principal at Ernst & Young LLP, Chief Financial Officer at Medicure, Inc. from 2011 to 2021, Manager at Manitoba Telecom Services, Inc., and Chief Financial Officer at Luminor Medical Technologies, Inc. from 2011 to 2016.
Education includes undergraduate studies at Asper School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 211,492 ( 3.9% ) 67 043 $ 30/05/2026
01/04/2026 47,100 ( 0.45% ) 37 868 $ 30/05/2026
04/05/2025 56,500 ( 0.1% ) 396 $ 30/05/2026

James Kinley active positions

CompaniesPositionStart
GREY MATTERS HEALTH INC. Director of Finance/CFO 30/11/2021
MEDICURE INC. Director/Board Member 15/06/2022
WAVERLEY PHARMA INC. Director/Board Member 19/06/2024
CYTOPHAGE TECHNOLOGIES LTD. Director of Finance/CFO 19/01/2026
Algernon Neuroscience, Inc.
Director of Finance/CFO -

Former positions of James Kinley

CompaniesPositionEnd
MEDICURE INC. Director of Finance/CFO 14/05/2021
Director of Finance/CFO 17/01/2016
Corporate Officer/Principal -
BELL MTS Corporate Officer/Principal -
See the detail of James Kinley's experience

Training of James Kinley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

24

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Commercial Services

Health Technology

Communications

Commercial Services

Consumer Services

Health Technology

Health Technology

Algernon Neuroscience, Inc.

Finance